8-K/A
Current Report
Indaptus Therapeutics, Inc. Filed Acc 0001493152-21-020145
Exit or restructuring costs · Impairment · Auditor change
- Item 2.05 Costs associated with exit or disposal activities
- Item 2.06 Material impairments
- Item 4.01 Changes in the registrant's certifying accountant
From the SEC's structured data for this filing
Loading form8-ka.htm…